Confronting Pancreatic Cancer

Pancreas Cancer News Center

Pancreatic Cancer News and Archives

For access to the Select Abstractssm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

Search our News and Archives

Keyword(s) to Search:
Options:

Browse by Quarter

2007 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2006 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2005 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2004 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2003 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2002 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2001 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2000 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2008 First Quarter

Short Time to Progression under First-Line Chemotherapy Is a Negative
Prognostic Factor for Time to Progression and Residual Survival under
Second-Line Chemotherapy in Advanced Pancreatic Cancer
May 23, 2008
...more

Survival in Familial Pancreatic Cancer
May 22, 2008
...more

Prospective Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine
and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
May 20, 2008
...more

Risk Factors Associated with Neuroendocrine Tumors: A U.S.-Based
Case-Control Study
May 19, 2008
...more

Radiolabeled DOTATOC in Patients with Advanced Paraganglioma and
Pheochromocytoma
May 16, 2008
...more

Clinical Significance and Regulation of the Costimulatory Molecule B7-H1
in Pancreatic Cancer
May 15, 2008
...more

Response to a Third-Line Mitomycin C (MMC)-Based Chemotherapy in a
Patient with Metastatic Pancreatic Adenocarcinoma Carrying Germline
BRCA2 Mutation
May 8, 2008
...more

Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the
Management of Pancreatic Cancer
May 7, 2008
...more

Primary Tumour Resection in Metastatic Nonfunctioning Pancreatic
Endocrine Carcinomas
May 5, 2008
...more

A Long-Term Survival Case of Unresectable Malignant Pancreatic Endocrine
Tumor Successfully Treated with Systemic Chemotherapy
May 1, 2008
...more

Borderline Resectable Pancreatic Cancer: The Importance of this Emerging
Stage of Disease
May 1, 2008
...more

Surgery and Radiofrequency Ablation for Treatment of Liver Metastases
from Midgut and Foregut Carcinoids and Endocrine Pancreatic Tumors
May 1, 2008
...more

Treatment with the Radiolabeled Somatostatin Analog [177 Lu-DOTA
0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
May 1, 2008
...more

Comparison Between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the Detection
of Gastro-Entero-Pancreatic and Lung Neuro-Endocrine Tumours
April 17, 2008
...more

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced
Pancreatic Cancer
April 17, 2008
...more

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body
Radiotherapy for Locally Advanced Pancreatic Cancer
April 1, 2008
...more

6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects
and Emerging Clinical Applications
April 1, 2008
...more

A Phase I Trial of Arterial Infusion Chemotherapy with Gemcitabine and
5-Fluorouracil for Unresectable Advanced Pancreatic Cancer after
Vascular Supply Distribution Via Superselective Embolization
April 1, 2008
...more

A Phase II Study Evaluating Bevacizumab in Combination with Fixed-Dose Rate
Gemcitabine and Low-Dose Cisplatin for Metastatic Pancreatic Cancer: Is an
Anti-VEGF Strategy Still Applicable?
April 1, 2008
...more

Brucea Javanica Fruit Induces Cytotoxicity and Apoptosis in Pancreatic
Adenocarcinoma Cell Lines
April 1, 2008
...more

Gemcitabine plus Celecoxib in Patients with Advanced or Metastatic
Pancreatic Adenocarcinoma: Results of a Phase II Trial
April 1, 2008
...more

Lapatinib/Gemcitabine and Lapatinib/Gemcitabine/Oxaliplatin: A Phase I Study for Advanced Pancreaticobiliary Cancer
April 1, 2008
...more

PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as
Second-Line Therapy in Patients with Progressive or Recurrent Pancreatic
Cancer after Gemcitabine-Containing Chemotherapy
April 1, 2008
...more

Requiem for the Term 'Carcinoid Tumour' in the Gastrointestinal Tract?
April 1, 2008
...more

What Constitutes a "High-Volume" Hospital for Pancreatic Resection?
April 1, 2008
...more

Meta-Analysis of Randomized Trials: Evaluation of Benefit from
Gemcitabine-Based Combination Chemotherapy Applied in Advanced
Pancreatic Cancer
March 28, 2008
...more

Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection for
Pancreatic Adenocarcinoma
March 25, 2008
...more

Improved Staging of Patients with Carcinoid and Islet Cell Tumors with
18F-Dihydroxy-Phenyl-Alanine and 11C-5-Hydroxy-Tryptophan Positron
Emission Tomography
March 20, 2008
...more

Most Pancreatic Cancer Resections are R1 Resections
March 20, 2008
...more

Efficacy and Safety of Pemetrexed in Elderly Cancer Patients: Results of
an Integrated Analysis
March 19, 2008
...more

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using
Cetuximab as a Targeting Agent
March 15, 2008
...more

A Pilot Study on Combination of Cryosurgery and (125)Iodine Seed
Implantation for Treatment of Locally Advanced Pancreatic Cancer
March 14, 2008
...more

A Pilot Study of Perillyl Alcohol in Pancreatic Cancer
March 13, 2008
...more

Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients
With Cancer Based on the Modeling of Preclinical and Clinical
Pharmacokinetic and Pharmacodynamic Data
March 10, 2008
...more

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid
Tumor: A Random Assignment Phase II Study of Depot Octreotide with
Bevacizumab and Pegylated Interferon Alpha-2b
March 10, 2008
...more

Evaluation of Unusual Neuroendocrine Tumours by Means of (68)Ga-DOTA-NOC PET
March 3, 2008
...more

Antitumor Activity of Rapamycin and Octreotide as Single Agents or in
Combination in Neuroendocrine Tumors
March 1, 2008
...more

Complete Response of CNS-Involved Olfactory Neuroendocrine Tumor using
Multimodal Therapy
March 1, 2008
...more

Curcumin (Diferuloylmethane) Alters the Expression Profiles of MicroRNAs
in Human Pancreatic Cancer Cells
March 1, 2008
...more

Feasibility Evaluation of Emodin (Rhubarb Extract) as an Inhibitor of
Pancreatic Cancer Cell Proliferation in Vitro
March 1, 2008
...more

Flavonoid Intake and Risk of Pancreatic Cancer in Male Smokers (Finland)
March 1, 2008
...more

Long-Term Survival after Pancreatoduodenectomy for Pancreatic
Adenocarcinoma: Is Cure Possible?
...more

Pancreatic Cystic Neuroendocrine Tumors: Preoperative Diagnosis with Endoscopic
Ultrasound and Fine-Needle Immunocytology
March 1, 2008
...more

Prognostic Score Predicting Survival after Resection of Pancreatic
Neuroendocrine Tumors: Analysis of 3851 Patients
March 1, 2008
...more

Weekly Full-Dose Gemcitabine and Single-Dose Cisplatin with Concurrent Radiotherapy
in Patients with Locally Advanced Pancreatic Cancer
February 26, 2008
...more

Pilot Study of Mutant Ras Peptide-Based Vaccine as an Adjuvant Treatment in Pancreatic and Colorectal Cancers
February 23, 2008
...more

Full-Dose Gemcitabine with Concurrent Radiation Therapy in Patients with Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial
February 20, 2008
...more

Assessment of the Efficacy and Toxicity of (131)I-Metaiodobenzylguanidine Therapy for Metastatic Neuroendocrine Tumours
February 19, 2008
...more

Tumor Resensitization to Erlotinib Following Brief Substitution of Cetuximab
February 19, 2008
...more

Treatment of Unresectable Locally Advanced Pancreatic Cancer with
Combined Radiotherapy and Chemotherapy
February 18, 2008
...more

Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors
February 18, 2008
...more

Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors?
February 11, 2008
...more

Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer
February 7, 2008
...more

Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
February 5, 2008
...more

Biweekly Triple Combination Chemotherapy with Gemcitabine, Oxaliplatin,
Levofolinic Acid and 5-Fluorouracil (GOLF) is a Safe and Active
Treatment for Patients with Inoperable Pancreatic Cancer
February 1, 2008
...more

Cryosurgery with Combination of (125)Iodine Seed Implantation for the Treatment of Locally Advanced Pancreatic Cancer
February 1, 2008
...more

En bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels: Perioperative Outcome and Long-Term Survival in 136 Patients
February 1, 2008
...more

Excess toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study
February 1, 2008
...more

Intra-Arterial Infusion Chemotherapy with 5-Fluorouracil and Cisplatin
in Advanced Pancreatic Cancer: A Feasibility Study
February 1, 2008
...more

Transcatheter Arterial Chemoembolization (TACE) Using Degradable Starch Microspheres (DSM) (DSM-TACE) for Primary and Metastatic Liver Neuroendocrine Tumors from Gastrointestinal Neuroendocrine Tumors
February 1, 2008
...more

Prognostic Factors at Diagnosis and Value of WHO Classification in a Mono-Institutional Series of 180 Non-Functioning Pancreatic Endocrine Tumours
January 21, 2008
...more

Irinotecan Plus Gemcitabine and 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase II Study
January 11, 2008
...more

Report on Short-Term Side Effects of Treatments with (177)Lu-Octreotate in Combination with Capecitabine in Seven Patients with Gastroenteropancreatic Neuroendocrine Tumours
January 11, 2008
...more

Laparoscopic vs Open Resection of Pancreatic Endocrine Neoplasms: Single Institution's Experience over 14 Years
January 10, 2008
...more

Preoperative Chemoradiation in aDenocarcinoma of the Pancreas. A Single Centre Experience Advocating a New Treatment Strategy
January 9, 2008
...more

Results Following Surgical Resection for Malignant Pancreatic Neuroendocrine Tumours. A Single Institutional Experience
January 8, 2008
...more

A Multi-Centre Retrospective Review of Second-Line Therapy in Advanced Pancreatic Adenocarcinoma
January 3, 2008
...more

A Phase I Trial of Gemcitabine in Combination with Patupilone in Patients with Advanced Solid Tumors
January 3, 2008
...more

A Phase II Study of Capecitabine Plus Gemcitabine in Patients with Locally Advanced or Metastatic Pancreatic Cancer
January 3, 2008
...more

A Case of Salvage Chemotherapy with Gemcitabine Hydrochloride and Nedaplatin for Gemcitabine-Tefractory Pancreatic Cancer
January 1, 2008
...more

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-Pulsed
Dendritic Cells and Activated T Lymphocytes
January 1, 2008
...more
EGCG Inhibits Growth, Invasion, Angiogenesis and Metastasis of Pancreatic Cancer
January 1, 2008
...more

Functional MRI Evaluation of Tumor Response in Patients with Neuroendocrine Hepatic Metastasis Treated with Transcatheter Arterial Chemoembolization
January 1, 2008
...more

Improved Contemporary Surgical Management of Insulinomas: A 25-Year Experience at the Massachusetts General Hospital
January 1, 2008
...more

Improved Survival with Adjuvant External-Beam Radiation Therapy in Lymph Node-Negative Pancreatic Cancer: A United States Population-Based Assessment
January 1, 2008
...more

Interferon-Alpha in Combination with Chemotherapy has Potent Antiangiogenic Properties in an Orthotopic Mouse Model for Pancreatic Adenocarcinoma
January 1, 2008
...more

Neoadjuvant Chemoradiation in Patients with Potentially Resectable Pancreatic Cancer
January 1, 2008
...more

Pancreatic Neuroendocrine Tumours
January 1, 2008
...more

Thymic Carcinoid Responds to Neoadjuvant Therapy with Sunitinib and Octreotide: A Case Report
January 1, 2008
...more

2007
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2006
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2005
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2004
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2003
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2002
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2001
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2000
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Donations
FAQ | Clinical Trials Registry | Research Resources | About Us

webmaster

©2000-2008 Pancreatica.org - All Rights Reserved
www.pancreatica.org